Top Markets
Coin of the day
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
Ранг среди акций #13334
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Цена акции
$0.30840035
Рыночная капитализация
$94.37M
Изменение (1 день)
0.00%
Изменение (1 год)
-34.60%
Страна
FR
Торговля Sensorion SA (ALSEN)

Категория

История цены акций Sensorion SA (ALSEN)
Наивысшая цена закрытия: $0.30 2026-07-01

Наименьшая цена закрытия: $4.88 2015-04-01
История цены акций Sensorion SA с 2015 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -14.19%
2025 -35.43%
2024 42.20%
2023 21.00%
2022 -80.41%
2021 12.23%
2020 121.36%
2019 -30.56%
2018 -66.86%
2017 -29.31%
2016 -42.01%
2015 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$49.48 -28.22%
DK
$478.51 2.06%
US
$658.80 16.04%
US
$280.05 40.43%
BE
$868.37 55.00%
NL